
Acmecilin250 mg/via
ACME Laboratories Ltd.

Injection
Ampexin 250 mg/vial inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins (PBPs) which in turn inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls.
Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.
| Condition | Dosage | Notes |
|---|---|---|
| Intra-articular | Supplement in systemic therapy for treatment of susceptible infections- Adult: 500 mg daily | |
| Child | <10 yr Half of adult routine dosage | |
| Intraperitoneal | Supplement in systemic therapy for treatment of susceptible infections- Adult: 500 mg daily | |
| Child | <10 yr Half of adult routine dosage | |
| Intrapleural | Supplement in systemic therapy for treatment of susceptible infections- Adult: 500 mg daily | |
| Child | <10 yr Half of adult routine dosage Intravenous:Meningitis- Adult: 2 gm 6 hrly | |
| Child | 150 mg/kg daily in divided doses | Intrapartum prophylaxis against group B Streptoccocal infection in neonates- Adult: Initially, 2 gm via IV inj followed by 1 gm 4 hrly until delivery |
| Oral | Biliary tract infections, Bronchitis, Endocarditis, Gastroenteritis, Listeriosis, Otitis media, Perinatal streptococcal infections, Peritonitis- Adult: 0.25-1 gm 6 hrly | |
| Child | <10 yr Half of adult routine dosage | |
| Typhoid and paratyphoid fever- Adult | 1-2 gm 6 hrly for 2 wk in acute infections, and 4-12 wk in carriers | |
| Uncomplicated gonorrhoea- Adult | 2 gm with 1 gm of probenecid as single dose, recommended to be repeated in female patients | |
| Urinary tract infections- Adult | 500 mg 8 hrly | |
| Parenteral | Susceptible infections- Adult: 500 mg 6 hrly, via IM or slow IV inj over 3-5 min or by infusion | |
| Child | <10 yr Half of adult routine dosage | |
| Septicaemia- Adult | 150-200 mg/kg daily | Initiate with IV admin for at least 3 days, then continue with IM inj 3-4 hrly. Continue treatment for at least 48-72 hr after the patient has become asymptomatic or when there is evidence of bacterial eradication. Recommended treatment duration for infections caused by group-A β-haemolytic streptococci: At least 10-days, to prevent occurrence of acute rheumatic fever or acute glomerulonephritis |
| Child | Same as adult dose |
What is Ampexin 250 mg/vial used for?
Ampicillin is indicated in the treatment of infections caused by susceptible strains of the designated organism listed below: Infections of the Genitourinary Tract Including Gonorrhea: E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, and nonpenicillinase-producing N. gononhoeae. Infections of the Respiratory Tract: Nonpenicillinase-producing H. influenzae and staphylo…
What is the dosage of Ampexin 250 mg/vial?
Intra-articular:Supplement in systemic therapy for treatment of susceptible infections- Adult: 500 mg daily. Child: <10 yr Half of adult routine dosage. Intraperitoneal:Supplement in systemic therapy for treatment of susceptible infections- Adult: 500 mg daily. Child: <10 yr Half of adult routine dosage. Intrapleural:Supplement in systemic therapy for treatment of susceptible infections- Adult: 50…
What are the side effects of Ampexin 250 mg/vial?
Nausea, vomiting, diarrhoea, erythematous maculo-papular rashes, sore mouth, black/hairy tongue, rash, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, fever, joint pains, serum sickness-like symptoms, haemolytic anaemia, thrombocytopenia, leucopenia, neutropenia, coagulation disorders, prolonged bleeding time and prothrombin time, CNS toxicity (e.g. convulsio…
Who should not take Ampexin 250 mg/vial?
Hypersensitivity to ampicillin and other penicillins.
What precautions should be taken with Ampexin 250 mg/vial?
Patient with history of β-lactam allergy. During renal impairment, Pregnancy and lactation.
Is Ampexin 250 mg/vial safe during pregnancy and breastfeeding?
Pregnancy Category B. Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.